452 companies

Willow Biosciences

Market Cap: CA$5.8m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

WLLW

CA$0.035

7D

0%

1Y

-65.0%

Telomir Pharmaceuticals

Market Cap: US$136.3m

A pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism.

TELO

US$4.17

7D

-1.4%

1Y

-13.7%

Simply Solventless Concentrates

Market Cap: CA$73.5m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

HASH

CA$0.70

7D

16.7%

1Y

324.2%

Grey Wolf Animal Health

Market Cap: CA$37.6m

Operates as an animal health and wellness company in Canada.

WOLF

CA$1.06

7D

-0.9%

1Y

29.3%

Tiansheng Pharmaceutical Group

Market Cap: CN¥1.4b

Engages in the pharmaceutical manufacturing and circulation activities.

002872

CN¥4.26

7D

8.4%

1Y

-11.4%

Medicure

Market Cap: CA$9.3m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

MPH

CA$0.89

7D

18.7%

1Y

-22.6%

Adastra Holdings

Market Cap: CA$2.2m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

XTRX

CA$0.39

7D

-7.1%

1Y

-84.1%

Hunan Er-Kang Pharmaceutical

Market Cap: CN¥5.8b

Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

300267

CN¥2.83

7D

2.5%

1Y

6.8%

3D Medicines

Market Cap: HK$1.0b

A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the Mainland China.

1244

HK$4.18

7D

42.7%

1Y

-38.7%

ImmuneOnco Biopharmaceuticals (Shanghai)

Market Cap: HK$1.9b

A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.

1541

HK$4.57

7D

-7.5%

1Y

-73.1%

Sana Biotechnology

Market Cap: US$654.2m

A biotechnology company, focuses on utilizing engineered cells as medicines.

SANA

US$2.77

7D

9.9%

1Y

-68.9%

Matricelf

Market Cap: ₪55.8m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

MTLF

₪3.46

7D

0.2%

1Y

-30.9%

Adlai Nortye

Market Cap: US$84.1m

A clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China.

ANL

US$2.25

7D

-3.4%

1Y

-75.1%

GlycoMimetics

Market Cap: US$17.0m

Engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States.

GLYC

US$0.27

7D

3.2%

1Y

-90.4%

Starpharma Holdings

Market Cap: AU$41.2m

A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.

SPL

AU$0.10

7D

-4.8%

1Y

-20.0%

Sona Nanotech

Market Cap: CA$34.3m

Operates as a nanotechnology life sciences company.

SONA

CA$0.30

7D

0%

1Y

-31.8%

Avicanna

Market Cap: CA$38.6m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide.

AVCN

CA$0.35

7D

-5.3%

1Y

-37.7%

Elite Pharmaceuticals

Market Cap: US$513.8m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

ELTP

US$0.48

7D

0.2%

1Y

236.8%

Lionco Pharmaceutical GroupLtd

Market Cap: CN¥3.4b

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China.

603669

CN¥4.85

7D

1.0%

1Y

9.5%

Lepu Biopharma

Market Cap: HK$5.5b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally.

2157

HK$3.20

7D

-2.1%

1Y

-2.1%

Page 13 of 13